Neoleukin Therapeutics, Inc. Profile Avatar - Palmy Investing

Neoleukin Therapeutics, Inc.

Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic …

Drug Manufacturers - Specialty & Generic
US, Seattle [HQ]

Resulting Ratios

11 Records · Starting from 2012
Loading...
End of NLTX's Analysis
CIK: - CUSIP: 64049K104 ISIN: US64049K2033 LEI: - UEI: -
Secondary Listings
NLTX has no secondary listings inside our databases.